Study of Efficacy, Safety, and Pharmacokinetics of FCN-437c in Combination With Fulvestrant or Letrozole+Goserelin
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: FCN-437c+Fulvestrant|DRUG: FCN-437c+Letrozole+Goserelin
Sponsor: Ahon Pharmaceutical Co., Ltd.
Collaborators: Hebei Medical University Fourth Hospital|The First Hospital of Jilin University|Affiliated Hospital of Hebei University